drugset / Trial / NCT04584749

Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery

NCT04584749 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim is to analyze the effect of intravenous lidocaine administration on postoperative opioid use in patients undergoing upper abdominal cancer surgery. Specifically, those patients undergoing gastric cancer surgery and liver cancer surgery using a laparoscopic approach

Timeline

Start
2020-11-16
Primary completion
2023-04-01
Completion
2023-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications